case_images: PMC6008661_01
case_images: Fragments of bone tissue involved by epithelial neoplasia of follicular architecture, with foci of nondifferentiated (insular) carcinoma [Case 1].
case_images: CRIE2018-8749075.001.jpg
case_images: PMC6008661_01_CRIE2018-8749075.001.jpg
case_images: fig1
case_images: TTF-1, predominantly papillary (follicular variant), however with foci of nondifferentiated (insular) carcinoma (Figures 1 and 2). Thyroid ultrasonography showed a solid nodule of 20 mm in the right lobe and two solid hypoechogenic nodules of 11 and 9 mm in the left lobe, the smallest with coarse calcifications.
case_images: Malignant cells revealing intense and diffuse immunoexpression of thyroglobulin (cytoplasmic) (a) and TTF-1 (nuclear) (b) [Case 1].
case_images: CRIE2018-8749075.002.jpg
case_images: PMC6008661_01_CRIE2018-8749075.002.jpg
case_images: fig2
case_images: TTF-1, predominantly papillary (follicular variant), however with foci of nondifferentiated (insular) carcinoma (Figures 1 and 2). Thyroid ultrasonography showed a solid nodule of 20 mm in the right lobe and two solid hypoechogenic nodules of 11 and 9 mm in the left lobe, the smallest with coarse calcifications.
case_images: 18F-FDG-PET showing uptake of the radiopharmaceutical drug in thyroid left lobe, L5 vertebrae, and pelvic bones [Case 1].
case_images: CRIE2018-8749075.003.jpg
case_images: PMC6008661_01_CRIE2018-8749075.003.jpg
case_images: fig3
case_images: No lymphadenopathies were found. 18F-fluorodeoxyglucose positron-emission tomography (18F-FDG-PET) revealed a hypermetabolic focus in the left lobe of the thyroid, consistent with the suspected malignant neoplasia, and uptake of the radiopharmaceutical drug in the fifth lumbar vertebra and pelvic bones, consistent with secondary involvement (Figure 3).
case_images: Fragments of thyroid involved by papillary thyroid carcinoma of follicular and oxyphilic variants [Case 1].
case_images: CRIE2018-8749075.004.jpg
case_images: PMC6008661_01_CRIE2018-8749075.004.jpg
case_images: fig4
case_images: Histological examination revealed only follicular and oxyphilic variants of multifocal papillary carcinoma (at least six foci) and none of insular carcinoma, with dimensions ranging from 2 to 15 mm, without signs of hematogenic, lymphatic, or perineural permeation, as well as no signs of invasion of the capsule or extrathyroidal extension, with resection margins uninvolved by tumour (pT1b[m]NxM1R0) (Figure 4).
case_images: Posttherapy scintigraphy showing hyperfixation in the remnants of the sacrum and lower lumbar spine, bilateral iliac bone, and anterior cervical region [Case 1].
case_images: CRIE2018-8749075.005.jpg
case_images: PMC6008661_01_CRIE2018-8749075.005.jpg
case_images: fig5
case_images: Posttherapy scintigraphy showed hyperfixation in the remnants of the sacrum and lower lumbar spine, bilateral iliac bone, and anterior cervical region (Figure 5).
case_images: PMC6008661_02
case_images: Pelvic CT revealing a 9 cm lytic lesion of left iliac bone [Case 2].
case_images: CRIE2018-8749075.006.jpg
case_images: PMC6008661_02_CRIE2018-8749075.006.jpg
case_images: fig6
case_images: The patient underwent a pelvic CT, which revealed a 9 cm lytic lesion of left iliac bone with soft tissue involvement (Figure 6).
case_images: Fragments of bone tissue involved by epithelial neoplasia of follicular architecture [Case 2].
case_images: CRIE2018-8749075.007.jpg
case_images: PMC6008661_02_CRIE2018-8749075.007.jpg
case_images: fig7
case_images: TTF-1 showed iliac involvement of a well-differentiated thyroid carcinoma (Figures 7 and 8).
case_images: Malignant cells revealing intense and diffuse immunoexpression of thyroglobulin (cytoplasmic) (a) and TTF-1 (nuclear) (b) [Case 2].
case_images: CRIE2018-8749075.008.jpg
case_images: PMC6008661_02_CRIE2018-8749075.008.jpg
case_images: fig8
case_images: TTF-1 showed iliac involvement of a well-differentiated thyroid carcinoma (Figures 7 and 8).
case_images: 18F-FDG-PET revealing the pelvic lesion found on CT, without no other metabolically active lesions [Case 2].
case_images: CRIE2018-8749075.009.jpg
case_images: PMC6008661_02_CRIE2018-8749075.009.jpg
case_images: fig9
case_images: Postablative 131 iodine scintigraphy and 18F-FDG-PET (Figure 9) did not reveal further lesions.